nach oben

Knee Surgery, Sports Traumatology, Arthroscopy

Erschienen in:

01.01.2013 | Knee

Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy

verfasst von: A. Marmotti, F. Castoldi, R. Rossi, S. Marenco, A. Risso, M. Ruella, A. Tron, A. Borrè, D. Blonna, C. Tarella

Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate granulocyte colony-stimulating factor (G-CSF) efficacy in accelerating bone regeneration following opening-wedge high tibial valgus osteotomy for genu varum.

Methods

A phase II trial was conducted for evaluating the preoperative administration of G-CSF given at 10 μg/kg/day for 3 consecutive days with an additional half-dose 4 h before the opening-wedge high tibial valgus osteotomy. Overall, 12 patients (Group A) received G-CSF treatment, and the subsequent 12 patients (Group B) underwent surgery without G-CSF. The osteotomy gap was filled by a bone graft substitute. Bone marrow cell (BMC) mobilization was monitored by CD34+ve cell and clonogenic progenitor cell analysis. All patients underwent a clinical (Lysholm Knee Scale and SF-36) and radiographic evaluation preoperatively, as well as at given intervals postsurgery.

Results

All patients completed the treatment program without major side effects; G-CSF was well tolerated. BMC mobilization occurred in all Group A patients, with median peak values of circulating CD34+ve cells of 110/μL (range 29–256). Circulating clonogenic progenitors paralleled CD34+ve cell levels. A significant improvement in Lysholm Knee Scale was recorded at follow-up in Group A compared to Group B. At the radiographic evaluation, there was a significant increase in osseointegration at the bone-graft junction in Group A at 1, 2, 3 and 6 months postsurgery compared to Group B. The computerized tomography scan of the grafted area at 2 months postsurgery showed no significant difference in the quality of the newly formed bone between the two Groups.

Conclusions

Although the limited number of patients does not allow firm conclusions, the study suggests that G-CSF can be safely administered preoperatively in subjects undergoing opening-wedge high tibial valgus osteotomy; in addition, the clinical, radiographic and CT monitoring indicate that G-CSF and/or mobilized BMCs may hasten bone graft substitute osseointegration.

Level of evidence

Nur mit Berechtigung zugänglich

Aalderink KJ, Shaffer M, Amendola A (2010) Rehabilitation following high tibial osteotomy. Clin Sports Med 29:291–301PubMedCrossRef

Anderlini P (2009) Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol 16:35–40PubMedCrossRef

Anderlini P, Champlin RE (2008) Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111:1767–1772PubMedCrossRef

Baldo MP, Davel APC, Damas-Souza DM, Nicoletti-Carvalho JE, Bordin S, Carvalho HF, Rodrigues SL, Rossoni LV, Mill JG (2011) The antiapoptotic effect of granulocyte colony-stimulating factor reduces infarct size and prevents heart failure development in rats. Cell Physiol Biochem 28:33–40PubMedCrossRef

Bozlar M, Aslan B, Kalaci A, Baktiroglu L, Yanat AN, Tasci A (2005) Effects of human granulocyte-colony stimulating factor on fracture healing in rats. Saudi Med J 26:1250–1254PubMed

Brouard N, Driessen R, Short B, Simmons PJ (2010) G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption. Stem Cell Res 5:65–75PubMedCrossRef

Cesselli D, Beltrami AP, Rigo S, Bergamin N, D’Aurizio F, Verardo R, Piazza S, Klaric E, Fanin R, Toffoletto B, Marzinotto S, Mariuzzi L, Finato N, Pandolfi M, Leri A, Schneider C, Beltrami CA, Anversa P (2009) Multipotent progenitor cells are present in human peripheral blood. Circ Res 104:1225–1234PubMedCrossRef

Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES (1997) Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 15:368–377PubMedCrossRef

Chen Y, Jiang X, Gong J (2008) Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi. J Vasc Surg 47:1058–1065PubMedCrossRef

10.

Chiò A, Mora G, La Bella V, Caponnetto C, Mancardi G, Sabatelli M, Siciliano G, Silani V, Corbo M, Moglia C, Calvo A, Mutani R, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Bondesan P, Garbelli S, Mantovani S, Bendotti C, Tarella C (2011) Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve 43:189–195PubMedCrossRef

11.

Cho S-W, Lim JE, Chu HS, Hyun H-J, Choi CY, Hwang K-C, Yoo KJ, Kim D-I, Kim B-S (2006) Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A 76:252–263PubMed

12.

Dallari D, Savarino L, Stagni C, Cenni E, Cenacchi A, Fornasari PM, Albisinni U, Rimondi E, Baldini N, Giunti A (2007) Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89:2413–2420PubMedCrossRef

13.

Ekmekçi OB, Oztürk G, Ekmekçi H, Atay D, Yanaşik M, Anak S, Devecioğlu O (2009) Effects of rhG-CSF plus dexamethasone on hemostatic parameters in healthy granulocyte donors: role of u-PA and nitric oxide. Clin Appl Thromb Hemost 15:689–694PubMedCrossRef

14.

Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C (2006) Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 45:13–19PubMedCrossRef

15.

Gangji V, Hauzeur J-P, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A:1153–1160PubMed

16.

Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK (2012) Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142(3):505–512.e1

17.

Haas R, Murea S (1995) The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells. Cytokines Mol Ther 1:249–270PubMed

18.

Hack M, Mascha FG, Jobst BJ, Riegger GAJ, Griese DP (2008) A systemic combination therapy with granulocyte-colony stimulating factor plus erythropoietin aggravates the healing process of balloon-injured rat carotid arteries. Cardiovasc Drugs Ther 22:351–362PubMedCrossRef

19.

Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A (2009) Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 94:94–101PubMedCrossRef

20.

Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, Livingston DH (2011) Impact of enhanced mobilization of bone marrow derived cells to site of injury. J Trauma 71:283–291PubMedCrossRef

21.

Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E (1997) Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 126:600–607PubMed

22.

Hernigou P, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H (2006) Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 88(Suppl 1 Pt 2):322–327PubMed

23.

Ince H, Valgimigli M, Petzsch M, de Lezo JS, Kuethe F, Dunkelmann S, Biondi-Zoccai G, Nienaber CA (2008) Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis. Heart 94:610–616PubMedCrossRef

24.

Ishida K, Matsumoto T, Sasaki K, Mifune Y, Tei K, Kubo S, Matsushita T, Takayama K, Akisue T, Tabata Y, Kurosaka M, Kuroda R (2010) Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A 16:3271–3284PubMedCrossRef

25.

Jäger M, Jelinek EM, Wess KM, Scharfstädt A, Jacobson M, Kevy SV, Krauspe R (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4:34–43PubMedCrossRef

26.

Kaptan K, Ifran A, Beyan C, Sertkaya D (2007) Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation. Hematology 12:441–444PubMedCrossRef

27.

Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37:967–976PubMedCrossRef

28.

Kastrup J, Ripa RS, Wang Y, Jørgensen E (2006) Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Eur Heart J 27:2748–2754PubMedCrossRef

29.

Kaygusuz MA, Turan CC, Aydin NE, Temel I, Firat S, Bulut T, Kuku I (2006) The effects of G-CSF and naproxen sodium on the serum TGF-beta1 level and fracture healing in rat tibias. Life Sci 80:67–73PubMedCrossRef

30.

Klocke R, Kuhlmann MT, Scobioala S, Schäbitz W-R, Nikol S (2008) Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Curr Med Chem 15:968–977PubMedCrossRef

31.

Kocher MS, Steadman JR, Briggs KK, Sterett WI, Hawkins RJ (2004) Reliability, validity, and responsiveness of the Lysholm knee scale for various chondral disorders of the knee. J Bone Joint Surg Am 86-A:1139–1145PubMed

32.

Kuroda R, Matsumoto T, Miwa M, Kawamoto A, Mifune Y, Fukui T, Kawakami Y, Niikura T, Lee SY, Oe K, Shoji T, Kuroda T, Horii M, Yokoyama A, Ono T, Koibuchi Y, Kawamata S, Fukushima M, Kurosaka M, Asahara T (2010) Local transplantation of G-CSF-mobilized CD34+cells in a patient with tibial nonunion: a case report. Cell Transplant

33.

Lian WS, Lin H, Cheng WT, Kikuchi T, Cheng CF (2011) Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy. J Biomed Sci 18:26PubMedCrossRef

34.

Liongue C, Wright C, Russell AP, Ward AC (2009) Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 41:2372–2375PubMedCrossRef

35.

Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, Mastrogiacomo M, Cancedda R (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13:947–955PubMedCrossRef

36.

Marenco S, Bellato E, Marini E, Mortera S, Castoldi F, Borré A, Castellano S, La Russa M, Marmotti A, Cottino U (2011) The role of CT and DEXA in the evaluation of biomaterial HATriC graft osseointegration in high tibial osteotomy. Minerva Ortopedica e Traumatologica Agosto 62(4):45–239

37.

Martino M, Luise F, Oriana V, Console G, Moscato T, Mammì C, Messina G, Massara E, Irrera G, Piromalli A, Lombardo VT, Laganà C, Iacopino P (2007) Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cells. Tumori 93:155–159PubMed

38.

Matsumoto T, Kawamoto A, Kuroda R, Ishikawa M, Mifune Y, Iwasaki H, Miwa M, Horii M, Hayashi S, Oyamada A, Nishimura H, Murasawa S, Doita M, Kurosaka M, Asahara T (2006) Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169:1440–1457PubMedCrossRef

39.

Mifune Y, Matsumoto T, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Kwon S-M, Miwa M, Kurosaka M, Asahara T (2008) Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells 26:1395–1405PubMedCrossRef

40.

Moioli EK, Clark PA, Chen M, Dennis JE, Erickson HP, Gerson SL, Mao JJ (2008) Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3:e3922PubMedCrossRef

41.

Naina HV, Pruthi RK, Inwards DJ, Dingli D, Litzow MR, Ansell SM, William HJ, Dispenzieri A, Buadi FK, Elliott MA, Gastineau DA, Gertz MA, Hayman SR, Johnston PB, Lacy MQ, Micallef IN, Porrata LF, Kumar S (2011) Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization. Bone Marrow Transplant 46:291–293PubMedCrossRef

42.

Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL (2009) Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the national marrow donor program. Blood 113:3604–3611PubMedCrossRef

43.

Quillen K, Byrne P, Yau YY, Leitman SF (2009) Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone. Transfusion 49:513–518PubMedCrossRef

44.

Sasaki K, Kuroda R, Ishida K, Kubo S, Matsumoto T, Mifune Y, Kinoshita K, Tei K, Akisue T, Tabata Y, Kurosaka M (2008) Enhancement of tendon-bone osteointegration of anterior cruciate ligament graft using granulocyte colony-stimulating factor. Am J Sports Med 36:1519–1527PubMedCrossRef

45.

Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353–357PubMedCrossRef

46.

Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG (2011) Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am 93:1057–1063PubMedCrossRef

47.

Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640–644PubMedCrossRef

48.

Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH (2009) Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res 31:167–172PubMedCrossRef

49.

Solaroglu I, Jadhav V, Zhang JH (2007) Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 12:712–724PubMedCrossRef

50.

Spiel AO, Bartko J, Schwameis M, Firbas C, Siller-Matula J, Schuetz M, Weigl M, Jilma B (2011) Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost 105:655–662PubMedCrossRef

51.

Spiel AO, Siller-Matula J, Firbas C, Leitner JM, Russmueller G, Jilma B (2010) Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans. Platelets 21:464–469PubMedCrossRef

52.

Takano H, Ohtsuka M, Akazawa H, Toko H, Harada M, Hasegawa H, Nagai T, Komuro I (2003) Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 9:1121–1127PubMedCrossRef

53.

Tarella C, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Moglia C, Ulla M, Omedé P, Bella VL, Corbo M, Silani V, Siciliano G, Mora G, Caponnetto C, Sabatelli M, Chiò A (2010) Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy 12:50–59PubMedCrossRef

54.

Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H, Taniuchi S, Kaneko K, Adachi Y, Ikehara S (2008) Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J 72:1351–1358PubMedCrossRef

55.

Terayama H, Ishikawa M, Yasunaga Y, Yamasaki T, Hamaki T, Asahara T, Ochi M (2011) Prevention of osteonecrosis by intravenous administration of human peripheral blood-derived CD34-positive cells in a rat osteonecrosis model. J Tissue Eng Regen Med 5(1):32–40

56.

Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL (2007) Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the research on adverse drug events and reports project. Bone Marrow Transplant 40:185–192PubMedCrossRef

57.

Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct 4 expression, and plasticity. Stem Cells 23:1105–1112PubMedCrossRef

58.

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef

59.

Wu X, Yang S, Duan D, Liu X, Zhang Y, Wang J, Yang C, Jiang S (2008) A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits. J Rheumatol 35:2241–2248PubMedCrossRef

60.

Wu Y-D, Chien C-H, Chao YJ, Hamrick MW, Hill WD, Yu JC, Li X (2008) Granulocyte colony-stimulating factor administration alters femoral biomechanical properties in C57BL/6 mice. J Biomed Mater Res A 87:972–979PubMed

61.

Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, Proya E, Anagnostopoulos A, Fassas A (2005) G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33:108–119PubMedCrossRef

62.

Zhang Y, Wang L, Fu Y, Song H, Zhao H, Deng M, Zhang J, Fan D (2009) Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:430–431PubMedCrossRef

Titel: Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy
verfasst von: A. Marmotti
F. Castoldi
R. Rossi
S. Marenco
A. Risso
M. Ruella
A. Tron
A. Borrè
D. Blonna
C. Tarella
Publikationsdatum: 01.01.2013
Verlag: Springer-Verlag
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy / Ausgabe 1/2013
Print ISSN: 0942-2056
Elektronische ISSN: 1433-7347
DOI: https://doi.org/10.1007/s00167-012-2150-z

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy

Abstract

Purpose

Methods

Results

Conclusions

Level of evidence

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Level of evidence

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

The rapid evolution of knee osteotomies

The results of corrective osteotomy for valgus arthritic knees

Critical comments and questions to the publication “Getgood A, Collins B, Slynarski K, Kurowska E, Parker D, Engebretsen L, Macdonald PB, Litchfield R 2011 Short-term safety and efficacy of a novel high tibial osteotomy system: a case controlled study. Knee Surg Sports Traumatol Arthrosc”

The impact of a high tibial valgus osteotomy and unicondylar medial arthroplasty on the treatment for knee osteoarthritis: a meta-analysis

Short-term safety and efficacy of a novel high tibial osteotomy system: a case controlled study

The role of the tibial slope in sustaining and treating anterior cruciate ligament injuries

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie